查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083718

人工智慧在醫療診斷領域的市場：按組件、技術類型、部署方式、應用和最終用戶分類－2026-2032年全球市場預測

Artificial Intelligence in Medical Diagnostics Market by Component, Technology Type, Deployment Mode, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療診斷領域的人工智慧 (AI) 市場規模將達到 52.6 億美元，複合年成長率為 15.57%。

主要市場統計數據
基準年 2025 19.1億美元
預計年份：2026年 21.9億美元
預測年份 2032 52.6億美元
複合年成長率 (%) 15.57%

人工智慧在醫療診斷領域的應用正從實驗階段走向臨床基礎設施。醫院、影像中心、實驗室和遠端醫療提供者正在利用機器學習、深度學習、自然語言處理和電腦視覺技術來支援放射學、病理學、循環系統學、眼科學、腫瘤學、感染疾病學和急診醫學等領域的工作流程。

人工智慧醫療技術的普及應用主要受以下幾個因素驅動：診斷數量的增加、臨床醫生短缺、醫學影像診斷的擴展、電子健康記錄的普及，以及美國FDA等監管機構對人工智慧醫療設備的批准。該領域的發展日益依賴臨床檢驗的演算法、互通性的部署、可解釋的輸出結果、網路安全，以及能夠證明其在準確性、速度、可訪問性或工作流程效率方面有所改進的證據。

診斷人工智慧領域的變革性變化

診斷人工智慧的發展趨勢正從單一任務工具轉向整合於影像歸檔和通訊系統（PACS）、實驗室資訊系統、電子健康記錄（EHR）、數位病理系統和臨床決策支援環境的診斷平台。儘管基於影像的診斷人工智慧仍然是最成熟的應用領域，但隨著數位資料可用性的提高，病理學、基因組學、分診、遠距監護和多模態診斷等領域也在不斷擴展。

人工智慧在診斷領域的累積影響

人工智慧正透過減少重複的人工審查、標記高優先級觀察、標準化測量以及幫助臨床醫生識別複雜數據中的細微模式，對整個診斷價值鏈產生累積性影響。在高通量檢測環境中，人工智慧可以透過優先處理與中風、肺動脈栓塞、結核病、糖尿病視網膜病變、膿毒症風險和癌症相關的觀察，縮短檢測結果的報告累積。

關鍵區域洞察：全球人工智慧診斷市場

亞太地區發展迅速，中國、日本、印度、韓國、澳洲和東南亞國協都在投資建置數位化醫院、影像技術、電子健康記錄和大規模人口篩檢。儘管該地區受益於龐大的患者群體、不斷發展的醫療技術生態系統和政府主導的數位化醫療項目，但各國在報銷體系、互通性和數據管治仍存在顯著差異。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

在東協，醫院數位化、遠距遠端醫療的普及以及新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國的國家級人工智慧戰略正在推動人工智慧發展。尤其需要擴充性的診斷人工智慧工具，以改善患者獲得專科醫生服務的途徑，並支援在地域分散的人群中開展影像、病理、基層醫療分流和篩檢計畫。

重點國家洞察：人工智慧在診斷領域應用的主要市場

美國憑藉FDA已通過核准的人工智慧醫療設備、強大的醫院採購能力、先進的診斷影像網路和廣泛的臨床研究活動，在商業部署方面處於領先地位。加拿大則著重於負責任的人工智慧、研究成果的實用化、隱私權保護和公共部門評估。墨西哥和巴西正在擴展其數位醫療基礎設施，為放射學工作流程、篩檢、慢性病檢測和以患者為中心的診斷等領域提供了商機。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗且能帶來可衡量結果的應用案例，例如縮短檢測結果返回時間、提高靈敏度、減少重複檢測、早期發現或提高工作流程效率。解決方案必須能夠與現有臨床系統無縫整合，支援互通性標準，並最大限度地減少醫生、放射科醫生、病理學家和實驗室團隊的警報疲勞。

調查方法

本執行摘要基於二手研究和證據整合，參考了公開的監管資料庫、衛生當局出版刊物、同行評審的臨床文獻、醫院技術採用趨勢、醫療設備指南、數位健康政策、互通性標準和檢驗的行業資訊。

結論：人工智慧驅動的醫療診斷的未來

人工智慧正逐漸成為醫療診斷領域的戰略要地，在診斷影像、病理學、臨床檢驗醫學、基因組學和臨床決策支援等領域提升速度、一致性和擴充性。當檢驗的演算法被整合到臨床醫生的工作流程中，並得到完善的管治、互通性、網路安全和實際應用監測支援時，其影響將最為顯著。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：人工智慧在醫療診斷領域的市場：按組件分類

  • 硬體
    • 記憶
    • 處理器
  • 軟體
    • 診斷軟體
    • 影像處理軟體
    • 預測分析軟體
  • 服務

第8章：人工智慧在醫療診斷領域的市場：按技術類型分類

  • 電腦視覺
  • 資料探勘
  • 深度學習
  • 機器學習
  • 自然語言處理

第9章：人工智慧在醫療診斷領域的市場：按部署模式分類

  • 基於雲端的
  • 現場

第10章：人工智慧在醫療診斷領域的市場：按應用分類

  • 醫學影像和診斷應用
    • 循環系統
    • 神經病學
    • 婦產科
    • 腫瘤學
    • 眼科
    • 放射科
  • 體外診斷應用
    • 伴隨診斷
    • 免疫檢測測定診斷
    • 分子診斷
  • 個人化醫療
  • 遠端監測和遠端醫療

第11章：人工智慧在醫療診斷領域的市場：按最終用戶分類

  • 學術機構
  • 診斷中心
  • 醫院
  • 研究所

第12章：人工智慧在醫療診斷領域的市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：人工智慧在醫療診斷領域的市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：人工智慧在醫療診斷領域的市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • 3M Company
  • AiCure, LLC
  • Aidoc Medical Ltd.
  • Butterfly Network, Inc.
  • Cera Care Limited
  • Cisco Systems, Inc.
  • Corti-AI
  • Cotiviti, Inc.
  • Digital Diagnostics Inc.
  • Enlitic, Inc.
  • Epredia by PHC Holdings Corporation
  • Freenome Holdings, Inc.
  • GE HealthCare Technologies, Inc.
  • General Vision, Inc.
  • Google LLC by Alphabet Inc.
  • Hewlett Packard Enterprise Development LP
  • Imagen Technologies, Inc.
  • Intel Corporation
  • International Business Machines Corporation
  • Johnson & Johnson Services, Inc.
  • Kantify
  • Koninklijke Philips NV
  • Medtronic PLC
  • Microsoft Corporation
  • Nano-X Imaging Ltd.
  • NEC Corporation
  • NVIDIA Corporation
  • Persistent Systems Limited
  • Qure.ai Technologies Private limited
  • Siemens Healthineers AG
  • SigTuple Technologies Private Limited
  • Stryker Corporation
  • Tempus Labs, Inc.
  • VUNO Inc.
Product Code: MRR-43492DACC312

The Artificial Intelligence in Medical Diagnostics Market is projected to grow by USD 5.26 billion at a CAGR of 15.57% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.91 billion
Estimated Year [2026] USD 2.19 billion
Forecast Year [2032] USD 5.26 billion
CAGR (%) 15.57%

Artificial intelligence in medical diagnostics is moving from experimentation to clinical infrastructure. Hospitals, imaging centers, laboratories, and virtual care providers are using machine learning, deep learning, natural language processing, and computer vision to support radiology, pathology, cardiology, ophthalmology, oncology, infectious disease, and emergency care workflows.

Adoption is supported by measurable forces: rising diagnostic volumes, clinician shortages, growth in medical imaging, expansion of electronic health records, and regulatory clearance of AI-enabled medical devices by authorities such as the U.S. FDA. The field is increasingly defined by clinically validated algorithms, interoperable deployment, explainable outputs, cybersecurity, and evidence of improved accuracy, speed, access, or workflow efficiency.

Transformative Shifts in the Diagnostic AI Landscape

The diagnostic AI landscape is shifting from single-task tools toward integrated diagnostic platforms embedded in PACS, laboratory information systems, EHRs, digital pathology systems, and clinical decision support environments. Imaging AI remains the most mature application area, while pathology, genomics, triage, remote monitoring, and multimodal diagnostics are expanding as digital data availability improves.

Regulatory expectations are also changing. Authorities are emphasizing transparency, post-market monitoring, bias evaluation, real-world performance, and lifecycle management for adaptive algorithms. At the same time, cloud computing, edge AI, federated learning, and synthetic data are reshaping how diagnostic models are trained and deployed while addressing privacy, cybersecurity, and data localization requirements.

Cumulative Impact of Artificial Intelligence on Diagnostics

Artificial intelligence is having a cumulative impact across the diagnostic value chain by reducing repetitive manual review, flagging urgent findings, standardizing measurements, and helping clinicians detect subtle patterns in complex data. In high-volume settings, AI can improve turnaround time by prioritizing suspected stroke, pulmonary embolism, tuberculosis, diabetic retinopathy, sepsis risk, and cancer-related findings.

The strongest value emerges when AI augments-not replaces-medical professionals. Evidence-backed deployment requires representative datasets, continuous performance monitoring, clinician oversight, and governance that addresses bias, consent, model drift, and liability. Organizations that connect AI outputs to clinical workflows achieve stronger adoption than those deploying standalone tools without operational integration.

Key Regional Insights: AI Diagnostics Across Global Markets

Asia-Pacific is advancing quickly as China, Japan, India, South Korea, Australia, and ASEAN markets invest in digital hospitals, imaging capacity, electronic medical records, and population-scale screening. The region benefits from high patient volumes, expanding health technology ecosystems, and government-backed digital health programs, although reimbursement, interoperability, and data governance vary widely across countries.

North America leads in regulatory clearances, clinical validation activity, enterprise AI adoption, and cloud-enabled diagnostics, with the United States acting as the primary commercialization hub and Canada emphasizing responsible AI, privacy protection, and public health integration. Europe is shaped by the EU AI Act, GDPR, CE marking, health data space initiatives, and strong clinical research networks, making compliance, transparency, and evidence generation central to market access.

Latin America, the Middle East, and Africa are adopting diagnostic AI to address access gaps, workforce shortages, and specialist scarcity. Brazil and Mexico are regional anchors in Latin America, supported by expanding digital health infrastructure and large urban hospital networks. The Middle East, particularly the GCC, is investing in smart hospitals, national AI strategies, and cloud-based health platforms. African markets show opportunity in radiology, tuberculosis screening, maternal health, ophthalmology, and mobile diagnostics, where infrastructure partnerships, affordability, and training remain critical to scalable implementation.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is gaining momentum through hospital digitization, telehealth adoption, and national AI strategies in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. Demand is strongest for scalable diagnostic AI tools that improve access to specialists and support imaging, pathology, primary care triage, and screening programs across geographically distributed populations.

The GCC is a high-investment environment for AI diagnostics, supported by digital health strategies in Saudi Arabia, the UAE, Qatar, and neighboring states, with strong emphasis on smart hospitals, preventive health, and data-driven care delivery. The European Union is anchored in regulatory rigor, interoperability, privacy protection, CE marking requirements, and cross-border research programs. BRICS countries combine large patient populations with growing AI research capacity and expanding digital health infrastructure, although infrastructure maturity, procurement systems, and regulatory pathways differ by country.

G7 markets remain leading adopters because of advanced health systems, established medical device oversight, high diagnostic procedure volumes, and stronger pathways for clinical evaluation. NATO countries also emphasize cybersecurity, trusted digital infrastructure, resilient health systems, and secure medical data exchange, making compliance, data protection, and operational resilience essential for diagnostic AI developers and healthcare providers.

Key Country Insights: Leading Markets for Diagnostic AI Adoption

The United States leads commercial deployment through FDA-cleared AI-enabled medical devices, strong hospital purchasing power, advanced imaging networks, and broad clinical research activity. Canada focuses on responsible AI, research translation, privacy safeguards, and public-sector evaluation. Mexico and Brazil are expanding digital health infrastructure and offer opportunities in radiology workflow, screening, chronic disease detection, and access-oriented diagnostics.

In Europe, the United Kingdom supports AI adoption through NHS innovation pathways, imaging networks, and diagnostic backlog reduction programs. Germany, France, Italy, and Spain combine strong clinical infrastructure with strict privacy, procurement, and medical device compliance requirements, while Russia maintains AI capabilities in imaging, public-sector digital health, and hospital modernization initiatives.

China is scaling AI diagnostics through large clinical datasets, hospital modernization, domestic algorithm development, and government support for medical AI applications. India's opportunity is driven by specialist shortages, high disease burden, expanding telemedicine, and scalable screening needs for tuberculosis, diabetic retinopathy, oncology, and cardiometabolic conditions. Japan prioritizes precision diagnostics, aging-population care, regulated innovation, and workflow automation. Australia and South Korea show strong readiness through digital health maturity, national health data infrastructure, research capacity, and advanced hospital systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated use cases with measurable outcomes such as reduced turnaround time, improved sensitivity, lower repeat testing, earlier detection, or enhanced workflow productivity. Solutions must integrate smoothly into existing clinical systems, support interoperability standards, and minimize alert fatigue for physicians, radiologists, pathologists, and laboratory teams.

Executives should build governance frameworks covering dataset quality, bias testing, cybersecurity, privacy, explainability, model monitoring, human oversight, and post-deployment performance review. Commercial teams should align evidence packages with regional regulatory and reimbursement expectations, while partnerships with hospitals, academic centers, cloud providers, standards bodies, and device manufacturers can accelerate adoption, validation, and trust.

Research Methodology

This executive summary is based on secondary research and evidence synthesis from public regulatory databases, health authority publications, peer-reviewed clinical literature, hospital technology adoption patterns, medical device guidance, digital health policies, interoperability standards, and verified industry disclosures.

The analysis prioritizes data-backed indicators including regulatory clearances, clinical validation requirements, digital health infrastructure, healthcare expenditure patterns, demographic pressures, disease burden, diagnostic workforce constraints, cybersecurity expectations, interoperability standards, and regional policy frameworks. Insights were cross-checked to avoid unsupported claims, market sizing, or forecasting and to reflect current realities in artificial intelligence in medical diagnostics.

Conclusion: The Future of AI-Enabled Medical Diagnostics

Artificial intelligence is becoming a strategic layer in medical diagnostics, improving speed, consistency, and scalability across imaging, pathology, laboratory medicine, genomics, and clinical decision support. Its impact is strongest where validated algorithms are embedded into clinician workflows and supported by governance, interoperability, cybersecurity, and real-world monitoring.

The next phase of adoption will favor technology developers and healthcare organizations that prove clinical value, protect patient data, address bias, and meet evolving regulatory expectations. AI in medical diagnostics is not a replacement for expert judgment; it is a data-driven augmentation engine for more accessible, efficient, and precise healthcare.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Intelligence in Medical Diagnostics Market, by Component

  • 7.1. Hardware
    • 7.1.1. Memory
    • 7.1.2. Processors
  • 7.2. Software
    • 7.2.1. Diagnostic Software
    • 7.2.2. Imaging Software
    • 7.2.3. Predictive Analysis Software
  • 7.3. Services

8. Artificial Intelligence in Medical Diagnostics Market, by Technology Type

  • 8.1. Computer Vision
  • 8.2. Data Mining
  • 8.3. Deep Learning
  • 8.4. Machine Learning
  • 8.5. Natural Language Processing

9. Artificial Intelligence in Medical Diagnostics Market, by Deployment Mode

  • 9.1. Cloud-Based
  • 9.2. On-Premise

10. Artificial Intelligence in Medical Diagnostics Market, by Application

  • 10.1. Imaging and Diagnostics Application
    • 10.1.1. Cardiology
    • 10.1.2. Neurology
    • 10.1.3. Obstetrics/Gynecology
    • 10.1.4. Oncology
    • 10.1.5. Ophthalmology
    • 10.1.6. Radiology
  • 10.2. In-Vitro Diagnostics Application
    • 10.2.1. Companion Diagnostics
    • 10.2.2. Immunoassay Diagnostics
    • 10.2.3. Molecular Diagnostics
  • 10.3. Personalized Medicine
  • 10.4. Remote Monitoring & Telehealth

11. Artificial Intelligence in Medical Diagnostics Market, by End-User

  • 11.1. Academic Institutions
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Research Laboratories

12. Artificial Intelligence in Medical Diagnostics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Artificial Intelligence in Medical Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Intelligence in Medical Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. 3M Company
  • 16.2. AiCure, LLC
  • 16.3. Aidoc Medical Ltd.
  • 16.4. Butterfly Network, Inc.
  • 16.5. Cera Care Limited
  • 16.6. Cisco Systems, Inc.
  • 16.7. Corti - AI
  • 16.8. Cotiviti, Inc.
  • 16.9. Digital Diagnostics Inc.
  • 16.10. Enlitic, Inc.
  • 16.11. Epredia by PHC Holdings Corporation
  • 16.12. Freenome Holdings, Inc.
  • 16.13. GE HealthCare Technologies, Inc.
  • 16.14. General Vision, Inc.
  • 16.15. Google LLC by Alphabet Inc.
  • 16.16. Hewlett Packard Enterprise Development LP
  • 16.17. Imagen Technologies, Inc.
  • 16.18. Intel Corporation
  • 16.19. International Business Machines Corporation
  • 16.20. Johnson & Johnson Services, Inc.
  • 16.21. Kantify
  • 16.22. Koninklijke Philips N.V.
  • 16.23. Medtronic PLC
  • 16.24. Microsoft Corporation
  • 16.25. Nano-X Imaging Ltd.
  • 16.26. NEC Corporation
  • 16.27. NVIDIA Corporation
  • 16.28. Persistent Systems Limited
  • 16.29. Qure.ai Technologies Private limited
  • 16.30. Siemens Healthineers AG
  • 16.31. SigTuple Technologies Private Limited
  • 16.32. Stryker Corporation
  • 16.33. Tempus Labs, Inc.
  • 16.34. VUNO Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEMORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEMORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEMORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PROCESSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PROCESSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IMAGING SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMAGING SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IMAGING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PREDICTIVE ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PREDICTIVE ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PREDICTIVE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COMPUTER VISION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPUTER VISION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COMPUTER VISION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DATA MINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DATA MINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DATA MINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DEEP LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DEEP LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DEEP LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MACHINE LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MACHINE LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ON-PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ON-PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ON-PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMAGING AND DIAGNOSTICS APPLICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IMAGING AND DIAGNOSTICS APPLICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMAGING AND DIAGNOSTICS APPLICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OBSTETRICS/GYNECOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OBSTETRICS/GYNECOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OBSTETRICS/GYNECOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RADIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RADIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS APPLICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS APPLICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS APPLICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IMMUNOASSAY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMMUNOASSAY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IMMUNOASSAY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL REMOTE MONITORING & TELEHEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL REMOTE MONITORING & TELEHEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL REMOTE MONITORING & TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 175. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 177. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 205. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 207. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 208. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 211. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 217. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 219. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 250. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 262. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 282. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 286. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 292. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 296. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 298. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY